GlassScriptPhysician profile
David A Brantley
NPI 1790706182
$26,651.71
in general payments reported to CMS, 2019-2025
46 companies · $1,011 in 2025
The $1,011 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $7,296 · 2021: $2,681 · 2022: $1,944 · 2023: $1,005 · 2024: $874 · 2025: $1,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,858 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,857.84 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $10,697.26 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $6,993.88 | 2019-2025 | Jardiance, Synjardy |
| Lilly USA, LLC | $3,627.43 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,670.20 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $553.10 | 2019-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $378.25 | 2019-2025 | |
| Tandem Diabetes Care, INC. | $296.67 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Radius Health, INC. | $267.64 | 2019-2025 | Tymlos |
| Insulet Corporation | $224.25 | 2019-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $223.85 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $155.71 | 2022-2025 | |
| Amneal Pharmaceuticals LLC | $134.32 | 2022-2024 | Unithroid |
| Ascendis Pharma Endocrinology INC | $130.02 | 2023-2025 | Yorvipath |
| Mannkind Corporation | $125.30 | 2019-2025 | Afrezza |
| Abbvie INC. | $106.13 | 2019-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $90.86 | 2019-2025 | Tirosint, Licart, Tirosint |
| Xeris Pharmaceuticals, INC. | $82.45 | 2023-2025 | Gvoke Hypopen |
| Horizon Therapeutics Plc | $79.22 | 2021-2023 | Tepezza |
| Medtronic, INC. | $67.75 | 2022-2024 | Minimed 780g |
| Abbott Laboratories | $53.00 | 2022-2024 | Freestyle Libre 3 |
| Kyowa Kirin, INC. | $51.91 | 2023 | Crysvita |
| Ascensia Diabetes Care US INC. | $51.90 | 2019-2023 | |
| Corcept Therapeutics | $49.24 | 2019-2024 | Korlym |
| Esperion Therapeutics, INC. | $43.71 | 2022-2024 | Nexletol |
| Cequr Corporation | $41.86 | 2022-2023 | Cequr Simplicity |
| Dexcom, INC. | $39.45 | 2022 | |
| Beta Bionics, INC. | $34.83 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Pfizer INC. | $26.95 | 2022 | |
| Eisai INC. | $26.19 | 2019 | |
| Shire North American Group INC | $25.96 | 2019 | |
| Recordati_rare_diseases_inc. | $25.86 | 2022 | |
| Eusa Pharma (US) LLC | $25.86 | 2022 | |
| Renalytix Ai, INC. | $24.34 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Rhythm Pharmaceuticals, INC. | $22.50 | 2025 | Imcivree |
| Lifescan, INC. | $20.20 | 2022 | |
| Senseonics, Incorporated | $20.00 | 2019 | |
| Amryt Pharma Holdings LTD | $19.20 | 2023 | Mycapssa |
| Sequel Med Tech, LLC | $18.55 | 2025 | Twiist |
| Grt US Holding, INC. | $18.08 | 2022 | |
| Alexion Pharmaceuticals, INC. | $17.95 | 2019 | |
| Amarin Pharma, INC. | $17.50 | 2019 | |
| Medtronic Minimed, INC. | $16.84 | 2020 | |
| Intuity Medical INC | $15.95 | 2022 | |
| Acella Pharmaceuticals, LLC | $14.96 | 2023 | NP Thyroid 60 |
| Vivus LLC | $12.94 | 2019 | |
| Companion Medical, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brantley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.